Anandamide‐induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels

British Journal of Pharmacology - Tập 134 Số 5 - Trang 1003-1012 - 2001
J. J. Grainger1, G. Boachie‐Ansah1
1Institute of Pharmacy and Chemistry, University of Sunderland, Dale Building, Sunderland SR1 3SD.

Tóm tắt

The effects of the endocannabinoid, anandamide, and its metabolically stable analogue, methanandamide, on induced tone were examined in sheep coronary artery rings in vitro.

In endothelium‐intact rings precontracted to the thromboxane A2 mimetic, U46619, anandamide (0.01 – 30 μM) induced slowly developing concentration‐dependent relaxations (pEC50 [negative log of EC50]=6.1±0.1; Rmax [maximum response]=81±4%). Endothelium denudation caused a 10 fold rightward shift of the anandamide concentration‐relaxation curve without modifying Rmax. Methanandamide was without effect on U46619‐induced tone.

The anandamide‐induced relaxation was unaffected by the cannabinoid receptor antagonist, SR 141716A (3 μM), the vanilloid receptor antagonist, capsazepine (3 and 10 μM) or the nitric oxide synthase inhibitor, L‐NAME (100 μM).

The cyclo‐oxygenase inhibitor, indomethacin (3 and 10 μM) and the anandamide amidohydrolase inhibitor, PMSF (70 and 200 μM), markedly attenuated the anandamide response. The anandamide transport inhibitor, AM 404 (10 and 30 μM), shifted the anandamide concentration‐response curve to the right.

Precontraction of endothelium‐intact rings with 25 mM KCl attenuated the anandamide‐induced relaxations (Rmax=7±7%), as did K+ channel blockade with tetraethylammonium (TEA; 3 μM) or iberiotoxin (100 nM). Blockade of small conductance, Ca2+‐activated K+ channels, delayed rectifier K+ channels, KATP channels or inward rectifier K+ channels was without effect.

These data suggest that the relaxant effects of anandamide in sheep coronary arteries are mediated in part via the endothelium and result from the cellular uptake and conversion of anandamide to a vasodilatory prostanoid. This, in turn, causes vasorelaxation, in part, by opening potassium channels.

British Journal of Pharmacology (2001) 134, 1003–1012; doi:10.1038/sj.bjp.0704340

Từ khóa


Tài liệu tham khảo

10.1097/00005344-199303000-00011

10.1126/science.277.5329.1094

10.1016/S0014-2999(97)01297-1

10.1111/j.1469-7793.1999.00539.x

10.1172/JCI119677

10.1016/S0005-2760(98)00042-3

ELLIS E.F., 1995, Anandamide and Δ9‐THC dilation of cerebral arterioles is blocked by indomethacin, Am. J. Physiol., 269, H1859

10.1016/S0898-6568(98)00060-6

10.1038/sj.bjp.0702381

FULTON D., 1998, Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide‐independent coronary vasodilator effect of bradykinin in the rat, J. Pharmacol. Exp. Ther., 286, 1146

10.1152/ajpheart.1999.276.6.H2085

GRAINGER J., 2000, The role of the endothelium and arachidonic acid metabolites in the vasorelaxant actions of anandamide in sheep coronary arteries, Br. J. Pharmacol., 131, 75P

ISHIOKA N., 1999, A role for N‐arachidonoylethanolamine (anandamide) as the mediator of sensory nerve‐dependent Ca2+‐induced relaxation, J. Pharmacol. Exp. Ther., 289, 245

10.1016/S0090-6980(00)00056-3

LAKE K.D., 1997, Cannabinoid‐induced hypotension and bradycardia in rats is mediated by CB1‐like cannabinoid receptors, J. Pharmacol. Exp. Ther., 281, 1030

10.1042/bj3460835

10.1074/jbc.275.18.13484

10.1038/sj.bjp.0702483

10.1152/ajpcell.1995.268.4.C799

10.1016/0014-2999(94)00618-H

10.1038/sj.bjp.0701361

10.1152/ajpheart.1998.274.1.H375

10.1038/sj.bjp.0703456

10.1006/bbrc.1996.1766

10.1016/S0014-2999(97)01237-5

10.1016/S0165-6147(97)01161-9

10.1016/S0014-2999(98)00003-X

10.1016/S0014-2999(97)01137-0

10.1038/sj.bjp.0703050

10.1006/bbrc.1998.8187

SZALLASI A., 1999, Vanilloid (capsaicin) receptors and mechanisms, Pharmacol. Rev., 51, 159

10.1038/sj.bjp.0703521

10.1161/01.HYP.33.1.429

10.1038/sj.bjp.0701546

10.1038/sj.bjp.0702127

10.1038/sj.bjp.0702111

ZOU A.P., 1994, Effects of 17‐octadecynoic acid, a suicide‐substrate inhibitor of cytochrome P450 fatty acid ω‐hydrolase, on renal function in rats, J. Pharmacol. Exp. Ther., 268, 474

10.1016/S0014-2999(00)00207-7

10.1038/sj.bjp.0701601

10.1038/22761

Thông tin
Thông tin xuất bản

British Journal of Pharmacology

Tập 134 Số 5

1003-1012

Thông tin tác giả